Ben Kiefel

Ben co-founded Myrio (then Affinity BIO) in 2009 and serves as COO and a Director. After starting his career in Evolutionary Biology, Ben realized early that he had an entrepreneurial flare and a passion for applied research and management of biotech businesses. In 2006, he started his first biotech venture which went on to commercialize its product internationally. Ben has been at Myrio’s heart since its inception – managing its administration, HR, operations, financing and science teams. Ben oversees Myrio’s Screening Team and together with Matt, he is co-inventor of the Myrio’s core technology (the ReD platform) and of numerous patents on protein display methods and compositions.